← Leaderboards
Erik J. Sorensen
Scripps Research Institute
$6,556,102
Attributed
$6,556,102
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $845.5K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,556,102 · 5
By mechanism
R01$6,267,097 · 4
P01$289,005 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Mirko Hennig$418,266
Others in their field
Top investigators on “Chemical Synthesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$156,891,547
- David H Walker · University Of Texas Medical Br Galveston$61,066,312
- Jay D Keasling · University Of California-Berkeley$45,089,571
- Marc A Hillmyer · University Of Minnesota-Twin Cities$43,647,280
- Huw M Davies · Suny At Buffalo$42,517,196
- Harry B Gray · California Institute Of Technology$40,481,419
Research focus
Chemical SynthesisComplexProgramsStructureBiological FactorsMolecularPropertyInnovationAnalogBiologicalArchitectureBaseDesignReactionChemical ReactionInsightDrug Design /Synthesis /ProductionMolecular StructureChemical BindingAchievementCancer CellHuman DiseaseLeadMalignant Neoplasm Of Cervix Uteri
Grant awards (30)
Seeking efficiency and innovation in syntheses of bioactive compounds$334,579
R01 · FY2015 · GM · contact PI
Seeking efficiency and innovation in syntheses of bioactive compounds$333,383
R01 · FY2014 · GM · contact PI
Seeking efficiency and innovation in syntheses of bioactive compounds$320,589
R01 · FY2013 · GM · contact PI
Seeking efficiency and innovation in syntheses of bioactive compounds$331,079
R01 · FY2012 · GM · contact PI
Synthesis of Bioactive Natural Products$307,348
R01 · FY2011 · GM · contact PI
Synthesis of Bioactive Natural Products$311,614
R01 · FY2010 · GM · contact PI
Synthesis of Bioactive Natural Products$315,877
R01 · FY2009 · GM · contact PI
Chemical Synthesis of Kendomycin and Garsubellin A$259,215
R01 · FY2009 · GM · contact PI
Synthesis of Bioactive Natural Products$316,842
R01 · FY2008 · GM · contact PI
Strategies and Methods for Complex Alkaloid Synthesis$269,486
R01 · FY2008 · GM · contact PI
Chemical Synthesis of Kendomycin and Garsubellin A$259,215
R01 · FY2008 · GM · contact PI
Strategies and Methods for Complex Alkaloid Synthesis$270,259
R01 · FY2007 · GM · contact PI
Chemical Synthesis of Kendomycin and Garsubellin A$241,506
R01 · FY2007 · GM · contact PI
Synthesis of inhibitors of HIV-Rev function$71,881
P01 · FY2007 · GM · contact PI
Synthesis of Bioactive Natural Products$281,388
R01 · FY2006 · GM · contact PI
Strategies and Methods for Complex Alkaloid Synthesis$279,059
R01 · FY2006 · GM · contact PI
Synthesis of inhibitors of HIV-Rev function$56,532
P01 · FY2006 · GM · contact PI
Synthesis of Bioactive Natural Products$289,030
R01 · FY2005 · GM
Strategies and Methods for Complex Alkaloid Synthesis$286,521
R01 · FY2005 · GM
Synthesis of inhibitors of HIV-Rev function$55,002
P01 · FY2005 · GM
Synthesis of Bioactive Natural Products$289,770
R01 · FY2004 · GM
Synthesis of inhibitors of HIV-Rev function$53,516
P01 · FY2004 · GM
Synthesis of Bioactive Natural Products$161,393
R01 · FY2003 · GM
Synthesis of Bioactive Natural Products$156,444
R01 · FY2003 · GM
SYNTHESIS OF WS9885B, A NOVEL CYTOTOXIC TUBULIN BINDER$115,899
R01 · FY2003 · CA
Synthesis of inhibitors of HIV-Rev function$52,074
P01 · FY2003 · GM
SYNTHESIS OF WS9885B, A NOVEL CYTOTOXIC TUBULIN BINDER$50,781
R01 · FY2003 · CA
SYNTHESIS OF WS9885B, A NOVEL CYTOTOXIC TUBULIN BINDER$166,680
R01 · FY2002 · CA
SYNTHESIS OF WS9885B, A NOVEL CYTOTOXIC TUBULIN BINDER$159,570
R01 · FY2001 · CA
SYNTHESIS OF WS9885B, A NOVEL CYTOTOXIC TUBULIN BINDER$159,570
R01 · FY2000 · CA